On September 22, 2021 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, reported the Company’s CEO Dr. Pnina Fishman will present at the Benzinga Healthcare Small Cap Conference on September 29, 2021 and will join a panel discussion regarding medical cannabis. Details are below (Press release, Can-Fite BioPharma, SEP 22, 2021, View Source [SID1234590136]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Medical Cannabis Panel

Date: Wednesday, September 29, 2021
Time: 11:55 am – 12:35 pm ET
To view live: link

Can-Fite Corporate Presentation

Date: Wednesday, September 29, 2021
Time: 12:35 pm – 12:55 pm ET
To view live: link